Centurion Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EB
AAMU
JWM
P
SAM
OIAM
SFA
TFA
Centurion Wealth Management's DGX Position: Q2 2026 in Review
Centurion Wealth Management reduced its Quest Diagnostics (DGX) stake by 24% in Q2 2026, selling an estimated $68.7K and leaving 1,110 shares worth $235K. The position accounts for 0.06% of the portfolio, ranked #259.
Centurion Wealth Management first reported a position in DGX in Q3 2025 and has held it in 4 quarters since. The position peaked at $286K in Q1 2026. 152 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Centurion Wealth Management held 1,110 shares of Quest Diagnostics worth $235K as of Q2 2026.
- Centurion Wealth Management sold 350 Quest Diagnostics shares in Q2 2026, an estimated $68.7K.
- Quest Diagnostics made up 0.06% of Centurion Wealth Management's portfolio in Q2 2026, its #259 holding.
- Centurion Wealth Management first reported a position in Quest Diagnostics in Q3 2025 and has held it in 4 quarters since.
- Centurion Wealth Management's Quest Diagnostics position peaked at $286K in Q1 2026.
- 152 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Centurion Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.